
Zenith Health Care Stock Falls to 52-Week Low of Rs.3.2 Amidst Market Underperformance
2025-11-28 11:49:47Zenith Health Care, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.3.2, reflecting continued downward pressure on its stock price despite a broadly positive market environment.
Read MoreWhy is Zenith Health falling/rising?
2025-11-17 22:37:10As of 17-Nov, Zenith Health Care Ltd's stock is currently priced at 3.80, reflecting a decrease of 0.02, or 0.52%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 1.81% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, with a 37.5% drop compared to the 5-day average, suggesting a decline in investor participation. Over the past year, the stock has seen a substantial decline of 30.15%, while the broader market, represented by the Sensex, has gained 9.50%. In the broader market context, Zenith Health's short-term performance has been notably poor compared to the Sensex, which has increased by 1.69% over the past week. This stark contrast highlights the stock's struggle to attract investor...
Read MoreHow has been the historical performance of Zenith Health?
2025-11-12 23:49:53Answer: The historical performance of Zenith Health shows a fluctuating trend in its financial metrics over the years. Breakdown: Zenith Health's net sales have seen a decline from INR 22.36 crore in March 2022 to INR 11.33 crore in March 2025, with a notable drop in March 2024 to INR 14.47 crore and INR 13.13 crore in March 2023. The total operating income followed a similar pattern, decreasing from INR 22.36 crore in March 2022 to INR 11.33 crore in March 2025. The company's total expenditure, excluding depreciation, also decreased from INR 21.90 crore in March 2022 to INR 11.24 crore in March 2025. Operating profit (PBDIT) has fluctuated, peaking at INR 0.98 crore in March 2022 and dropping to INR 0.52 crore by March 2025. Profit before tax remained stable at INR 0.28 crore in both March 2024 and March 2025, while profit after tax decreased from INR 0.31 crore in March 2022 to INR 0.07 crore in March 20...
Read MoreAre Zenith Health latest results good or bad?
2025-11-12 19:29:55Zenith Healthcare's latest financial results for Q2 FY26 present a mixed picture. The company reported a net profit of ₹0.14 crore, a significant recovery from a loss in the previous quarter, indicating a return to profitability. This recovery was primarily driven by improved operational efficiency, with the operating margin expanding to 7.93%, marking a notable improvement from the previous quarter's negative margin. However, the revenue performance raises concerns. The company experienced a decline in net sales, reporting ₹2.27 crore for the quarter, which represents a 27.94% decrease compared to the previous quarter and a 25.08% decline year-on-year. This sharp revenue contraction suggests underlying operational challenges and questions about the company's market demand and competitive positioning within the pharmaceutical sector. Despite the positive movement in profitability metrics, the overall fina...
Read More
Zenith Health Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns
2025-11-11 20:34:18Zenith Healthcare Limited, a micro-cap pharmaceutical manufacturer based in Gujarat, reported a net profit of ₹0.14 crores for Q2 FY26, reversing a loss of ₹0.02 crores in the previous quarter. However, this modest recovery came against a backdrop of significant revenue contraction, with net sales declining 27.94% quarter-on-quarter to ₹2.27 crores. The company's stock, trading at ₹3.81 with a market capitalisation of ₹21.00 crores, has plunged 33.62% over the past year, reflecting investor concerns about the sustainability of its business model.
Read MoreWhy is Zenith Health falling/rising?
2025-10-10 22:16:09As of 10-Oct, Zenith Health Care Ltd is experiencing a decline in its stock price, currently at 4.02, which represents a decrease of 0.1 or 2.43%. The stock has been underperforming, having fallen consecutively for the last three days, with a total return of -3.13% over that period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 27.1% compared to the 5-day average, suggesting a decline in investor participation. There is no information available regarding positive or negative factors that could influence the stock's movement. In the broader market context, Zenith Health's performance has been notably weaker than the benchmark, the Sensex, which has gained 1.59% over the past week while Zenith has lost 3.13%. Year-to-date, Zenith's stock has decreased by 22.39%, co...
Read MoreWhy is Zenith Health falling/rising?
2025-09-22 22:16:47As of 22-Sep, Zenith Health Care Ltd's stock price is currently at 4.35, reflecting a decrease of 0.02, or 0.46%. The stock has shown a mixed performance recently, with a 1-week return of -1.36% while outperforming its sector by 0.62% today. Despite a positive 1-month return of 14.17%, the stock has suffered significant losses year-to-date, down 16.02%, and has underperformed over the past year with a decline of 26.27%. The company is facing challenges, including operating losses and a weak ability to service its debt, indicated by a poor EBIT to Interest ratio of 0. Additionally, the stock is considered risky due to negative EBITDA and has shown below-par performance both in the long term and near term. In the broader market context, the Sensex has increased by 0.46% over the past week, contrasting with Zenith's decline. While the stock's recent performance has been bolstered by rising investor participat...
Read MoreWhy is Zenith Health falling/rising?
2025-09-19 22:10:25As of 19-Sep, Zenith Health Care Ltd's stock price is currently at 4.38, reflecting an increase of 0.07 or 1.62%. The stock has shown a positive performance today, outperforming its sector by 1.35%. In terms of returns, the stock has increased by 1.15% over the past week and 15.57% over the past month, indicating a strong short-term recovery despite a year-to-date decline of 15.44%. However, it is important to note that the stock's delivery volume has decreased by 1.97% compared to the 5-day average, suggesting a decline in investor participation. Additionally, while the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average, which may indicate mixed investor sentiment. Broader market context shows that the Sensex has increased by 0.88% over the past week and 1.20% over the past month, which highlights that Zenith Health's short-term perfo...
Read MoreWhy is Zenith Health falling/rising?
2025-09-17 22:05:04As of 17-Sep, Zenith Health Care Ltd's stock price is currently at 4.40, reflecting an increase of 0.06 or 1.38%. The stock has outperformed its sector today by 1.34%, and its current price is higher than the 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. Despite this positive movement, the stock has experienced a significant decline over the past year, with a return of -25.42%. The company is facing challenges, including operating losses and a weak ability to service its debt, as indicated by a poor EBIT to Interest ratio of 0. Additionally, the stock's profitability is low, with a Return on Equity of only 3.63%. The recent drop in investor participation, with a delivery volume decrease of 17.4%, further complicates its outlook. In the broader market context, Zenith Health's short-term return of +1.38% over the past week is slightly lower than the...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
12-Nov-2025 | Source : BSEPaper Cutting of Published Unaudited Financial Result for the Quater and Half Year ended 30th September 2025
Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025
11-Nov-2025 | Source : BSEUnaudited Standalone Financial Result of the Company
Board Meeting Outcome for Outcome Of Board Meeting
11-Nov-2025 | Source : BSEUnaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






